PMS Registry
Company Name
Pfizer Inc.
Protocol Number
Title of Study
Health-related quality life and health utility among Taiwanese women with advanced/metastatic breast cancer
Primary Objective
1.To provide a comprehensive picture of HRQoL in ethnically Chinese women with mBC by employing patient reported measures
2.To develop a mapping algorithm to predict EORTC QLQ-C30 and QLQ-BR23 questionnaires at individual patient level
3.To estimate health utilities associated with adverse events of breast cancer treatment
Number of Sites
Period of Study
From:Feb 6, 2017 to:Dec 31, 2018
Number of Patients
IRB Approval Date
Feb 6, 2017
Publication Plan / Date
Nov 30, 2019